Sansure Biotech Inc. (SHA:688289)
14.76
-0.25 (-1.67%)
Nov 17, 2026, 3:00 PM CST
Sansure Biotech Revenue
Sansure Biotech had revenue of 418.05M CNY in the quarter ending September 30, 2026, with 11.33% growth. This brings the company's total for the last twelve months to 1.65B, down -1.19% year-over-year. In the year 2025, Sansure Biotech had annual revenue of 1.64B with 12.58% growth. That makes Sansure Biotech the 15,948th largest company in the world by revenue and 2,884th in China.
Revenue (ttm)
1.65B
Revenue Growth
-1.19%
P/S Ratio
5.08
Revenue / Employee
775.27K
Employees
2,064
Market Cap
8.39B
Revenue by Geography
- China 1.53B 94.9%
- Overseas 83.08M 5.1%
Fiscal year ended Dec 31, 2025 See the full Sansure Biotech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.64B | 183.47M | 12.58% |
| Dec 31, 2024 | 1.46B | 450.94M | 44.78% |
| Dec 31, 2023 | 1.01B | -5.44B | -84.39% |
| Dec 31, 2022 | 6.45B | 1.94B | 42.88% |
| Dec 31, 2021 | 4.51B | -248.42M | -5.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Blue Sail Medical | 6.98B |
| Truking Technology | 5.89B |
| Tofflon Science and Technology Group | 5.15B |
| Zhonghong Pulin Medical Products | 2.75B |
| Autek China | 1.82B |
| Eyebright Medical Technology (Beijing) | 1.79B |
| Aidite (Qinhuangdao) Technology | 1.16B |
| Mingyue Optical Lens | 931.08M |